NCT00930631View on ClinicalTrials.gov

Study of [3H] BMS747158 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

January 31, 2010

Conditions
Coronary Artery Disease
Interventions
DRUG

[3H] BMS747158

Single bolus intravenous injection of \[3H\] BMS747158

Trial Locations (1)

53704

Covance Clinical Laboratory Unit, Madison

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY

NCT00930631 - Study of [3H] BMS747158 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter